Medscape

Diclofenac Oral Solution Approved for Migraines in Adults

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved diclofenac potassium for oral solution (Cambia, marketed by Kowa Pharmaceuticals America, Inc, under license from Applied ...
Drug Store News

Camber introduces sodium sulfate, potassium sulfate and magnesium sulfate oral solution

Camber is offering sodium sulfate, potassium sulfate and magnesium sulfate oral solution. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is an osmotic laxative indicated for ...
Morningstar

Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence ...

DUBLIN, Sept. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new real-world evidence and Phase 4 data reinforcing the value of Xywav® (calcium, magnesium, potassium, ...
Monthly Prescribing Reference

Klor-Con Powder for Oral Solution Now Available

Klor-Con Powder for oral solution is available as packets that contain 1.5g of potassium chloride (supplying potassium 20mEq and chloride 20mEq) in 30- and 100-count cartons. Upsher-Smith announced ...
Nasdaq

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex ...

DUBLIN, March 19, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that seven abstracts from across its neuroscience portfolio will be featured at the 77th Annual American ...